Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-24T14:43:22.020Z Has data issue: false hasContentIssue false

7 - Neuropathology of gliomas

Published online by Cambridge University Press:  05 March 2016

Darell D. Bigner ,
Allan H. Friedman ,
Henry S. Friedman  and
Roger McLendon
By
Roger McLendon  and
Thomas J. Cummings
Edited by
John H. Sampson
John H. Sampson
Affiliation:
Duke University Medical Center, Durham
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
The Duke Glioma Handbook
Pathology, Diagnosis, and Management
 , pp. 146 - 168
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bigner, DD. Biology of gliomas: potential clinical implications of glioma cellular heterogeneity. Neurosurgery, 1981;9(3):320–6.Google ScholarPubMed
Burger, PC, Vollmer, RT. Histologic factors of prognostic significance in the glioblastoma multiforme. Cancer, 1980;46(5):1179–86.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
McLendon, RE, Burger, PC, Pegram, CN, Eng, LF, Bigner, DD. The immunohistochemical application of three anti-GFAP monoclonal antibodies to formalin-fixed, paraffin-embedded, normal and neoplastic brain tissues. J Neuropathol Exp Neurol, 1986;45(6):692–703.CrossRefGoogle ScholarPubMed
Wikstrand, CJ, McLendon, RE, Friedman, AH, Bigner, DD. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Res, 1997; 57(18):4130–40.Google ScholarPubMed
Friedman, HS, McLendon, RE, Kerby, T, Dugan, M, Bigner, SH, Henry, AJ, et al. DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol, 1998;16(12):3851–7.CrossRefGoogle ScholarPubMed
The Cancer Genome Atlas Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 2008;455(7216):1061–8.Google Scholar
Parsons, DW, Li, M, Zhang, X, Jones, S, Leary, RJ, Lin, JC, et al. The genetic landscape of the childhood cancer medulloblastoma. Science, 2011;331(6016):435–9.CrossRefGoogle ScholarPubMed
Bettegowda, C, Agrawal, N, Jiao, Y, Sausen, M, Wood, LD, Hruban, RH, et al. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science, 2011;333(6048):4.CrossRefGoogle ScholarPubMed
Heaphy, CM, de Wilde, RF, Jiao, Y, Klein, AP, Edil, BH, Shi, C, et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science, 2011;333(6041):425.CrossRefGoogle ScholarPubMed
Jin, G, Cook, S, Cui, B, Chen, WC, Keir, ST, Killela, P, et al. HDMX regulates p53 activity and confers chemoresistance to 3-bis(2-chloroethyl)-1-nitrosourea. Neuro-Oncology, 2010;12(9):956–66.CrossRefGoogle ScholarPubMed
Killela, PJ, Pirozzi, CJ, Reitman, ZJ, Jones, S, Rasheed, BA, Lipp, E, et al. The genetic landscape of anaplastic astrocytoma. Oncotarget, 2014;5(6):1452–7.CrossRefGoogle ScholarPubMed
Burger, PC, Bigner, SH. Practical approaches to the diagnosis of central nervous system tumors. Mod Pathol, 1988;1(6):493–511.Google Scholar
Hunter, SB, Ballinger, WE, Jr., Rubin, JJ. Multiple sclerosis mimicking primary brain tumor. Arch Pathol Lab Med, 1987;111(5):464–8.Google ScholarPubMed
Prey, MU, Vitale, T, Martin, SA. Guidelines for practical utilization of intraoperative frozen sections. Arch Surg, 1989;124(3):331–5.CrossRefGoogle ScholarPubMed
Association of Directors of Anatomic and Surgical Pathology, Nakhleh, R, Coffin, C, Cooper, K. Recommendations for quality assurance and improvement in surgical and autopsy pathology. Hum Pathol, 2006;37(8):985–8.Google ScholarPubMed
Central Brain Tumor Registry of the United States. Supplement Report: Primary Brain Tumors in the United States, 2004. Hinsdale, IL: Central Brain Tumor Registry of the United States; 2008.Google Scholar
McLendon, RE, Rosenblum, MK, Bigner, DD. Russell and Rubinstein’s Pathology of Tumors of the Nervous System. London: Edward Arnold; 2006.CrossRefGoogle Scholar
Daumas-Duport, C, Scheithauer, B, O’Fallon, J, Kelly, P. Grading of astrocytomas. A simple and reproducible method. Cancer, 1988;62(10):2152–65.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
Yan, H, Parsons, DW, Jin, G, McLendon, R, Rasheed, BA, Yuan, W, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med, 2009;360(8):765–73.CrossRefGoogle ScholarPubMed
Camelo-Piragua, S, Jansen, M, Ganguly, A, Kim, JC, Cosper, AK, Dias-Santagata, D, et al. A sensitive and specific diagnostic panel to distinguish diffuse astrocytoma from astrocytosis: chromosome 7 gain with mutant isocitrate dehydrogenase 1 and p53. J Neuropathol Exp Neurol, 2011;70(2):110–15.CrossRefGoogle ScholarPubMed
Montine, TJ, Vandersteenhoven, JJ, Aguzzi, A, Boyko, OB, Dodge, RK, Kerns, BJ, et al. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery, 1994;34(4):674–8; discussion 678–9.Google ScholarPubMed
Li, FP, Fraumeni, JF Jr, Mulvihill, JJ, Blattner, WA, Dreyfus, MG, Tucker, MA, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res, 1988;48(18):5358–62.Google Scholar
Hamilton, SR, Liu, B, Parsons, RE, Papadopoulos, N, Jen, J, Powell, SM, et al. The molecular basis of Turcot's syndrome. N Engl J Med, 1995;332(13):839–47.CrossRefGoogle Scholar
Burger, PC, Kleihues, P. Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies. Cancer, 1989;63(10):2014–23.3.0.CO;2-L>CrossRefGoogle ScholarPubMed
Kepes, JJ. Astrocytomas: old and newly recognized variants, their spectrum of morphology and antigen expression. Can J Neurol Sci, 1987;14(2):109–21.CrossRefGoogle ScholarPubMed
Zlatescu, MC, TehraniYazdi, A, Sasaki, H, Megyesi, JF, Betensky, RA, Louis, DN, et al. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res, 2001;61(18):6713–15.Google ScholarPubMed
Scherer, HJ. The forms of growth in gliomas and their practical significance. Brain, 1940;63:1–35.CrossRefGoogle Scholar
Jiao, Y, Killela, PJ, Reitman, ZJ, Rasheed, AB, Heaphy, CM, de Wilde, RF, et al. Frequent ATRX, CIC, and FUBP1 mutations refine the classification of malignant gliomas. Oncotarget, 2012;3(7):709–22.CrossRefGoogle ScholarPubMed
Killela, PJ, Pirozzi, CJ, Healy, P, Reitman, ZJ, Lipp, E, Rasheed, BA, et al. Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas. Oncotarget, 2014;5(6):1515–25.CrossRefGoogle ScholarPubMed
Burger, PC, Rawlings, CE, Cox, EB, McLendon, RE, Schold, SC Jr, Bullard, DE. Clinicopathologic correlations in the oligodendroglioma. Cancer, 1987;59(7):1345–52.3.0.CO;2-A>CrossRefGoogle Scholar
McLendon, RE, Herndon, JE, West, B, Reardon, D, Wiltshire, R, Rasheed, BK, et al. Survival analysis of presumptive prognostic markers among oligodendrogliomas. Cancer, 2005;104(8):1693–9.CrossRefGoogle ScholarPubMed
Mittler, MA, Walters, BC, Stopa, EG. Observer reliability in histological grading of astrocytoma stereotactic biopsies. J Neurosurg, 1996;85(6):1091–4.CrossRefGoogle ScholarPubMed
Louis, DN, Ohgaki, H., Wiestler, OD, Cavenee, WK, Burger, PC, Jouvet, A, et al. WHO Classification of Tumours of the Central Nervous System. Lyons: IARC Press; 2006.Google Scholar
Daumas-Duport, C, Tucker, ML, Kolles, H, Cervera, P, Beuvon, F, Varlet, P, et al. Oligodendrogliomas. Part II: a new grading system based on morphological and imaging criteria. J Neurooncol, 1997;34(1):61–78.CrossRefGoogle Scholar
Daumas-Duport, C, Varlet, P, Tucker, ML, Beuvon, F, Cervera, P, Chodkiewicz, JP. Oligodendrogliomas. Part I: patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol, 1997;34(1):37–59.CrossRefGoogle ScholarPubMed
Central Brain Tumor Registry of the United States. Statistical Report: Primary Brain Tumors in the United States, 1995–1999. Hinsdale, IL: Central Brain Tumor Registry of the United States; 2002.Google Scholar
Jacob, K, Albrecht, S, Sollier, C, Faury, D, Sader, E, Montpetit, A, et al. Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours. Br J Cancer, 2009;101(4):722–33.CrossRefGoogle Scholar
Verhoeff, FH. Tumors of the optic nerve. In: Penfield, W, ed. Cytology and Cellular Pathology of the Nervous System, vol. 3. New York: Hafner; 1932.Google Scholar
Hayostek, CJ, Shaw, EG, Scheithauer, B, O’Fallon, JR, Weiland, TL, Schomberg, PJ, et al. Astrocytomas of the cerebellum. A comparative clinicopathologic study of pilocytic and diffuse astrocytomas. Cancer, 1993;72(3):856–69.Google Scholar
TomlinsonFH, Scheithauer BW, Hayostek, CJ, Parisi, JE, Meyer, FB, Shaw, EG, et al. The significance of atypia and histologic malignancy in pilocytic astrocytoma of the cerebellum: a clinico-pathologic and flow cytometric study. J Child Neurol, 1994;9:301–10.CrossRefGoogle Scholar
Giannini, C, Scheithauer, BW, Burger, PC, Christensen, MR, Wollan, PC, Sebo, TJ, et al. Cellular proliferation in pilocytic and diffuse astrocytomas. J Neuropathol Exp Neurol, 1999;58(1):46–53.CrossRefGoogle ScholarPubMed
Goldman, JE, Corbin, E. Rosenthal fibers contain ubiquitinated alpha B-crystallin. Am J Pathol, 1991;139(4):933–8.Google Scholar
Jones, DT, Kocialkowski, S, Liu, L, Pearson, DM, Backlund, LM, Ichimura, K, et al. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res, 2008;68(21):8673–7.CrossRefGoogle ScholarPubMed
Kepes, JJ, Rubinstein, LJ, Eng, LF. Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases. Cancer, 1979;44(5):1839–52.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
Giannini, C, Scheithauer, BW, Burger, PC, Brat, DJ, Wollan, PC, Lach, B, et al. Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer, 1999;85(9):2033–45.3.0.CO;2-Z>CrossRefGoogle Scholar
Dias-Santagata, D, Lam, Q, Vernovsky, K, Vena, N, Lennerz, JK, Borger, DR, et al. BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications. PLoS ONE, 2011;6(3):e17948.CrossRefGoogle ScholarPubMed
Fisher, BJ, Bauman, GS, Leighton, CE, Stitt, L, Cairncross, JG, Macdonald, DR. Low-grade gliomas in children: tumor volume response to radiation. J Neurosurg, 1998;88(6):969–74.CrossRefGoogle ScholarPubMed
Yoshimura, J, Onda, K, Tanaka, R, Takahashi, H. Clinicopathological study of diffuse type brainstem gliomas: analysis of 40 autopsy cases. Neurol Med Chir (Tokyo), 2003;43(8):375–82.CrossRefGoogle ScholarPubMed
Tomita, T, McLone, DG, Naidich, TP. Brain stem gliomas in childhood. Rational approach and treatment. J Neurooncol, 1984;2:117–22.CrossRefGoogle ScholarPubMed
Parsons, DW, Jones, S, Zhang, X, Lin, JC, Leary, RJ, Angenendt, P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science, 2008;321(5897):1807–12.CrossRefGoogle ScholarPubMed
Witt, H, Mack, SC, Ryzhova, M, Bender, S, Sill, M, Isserlin, R, et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell, 2011;20(2):143–57.CrossRefGoogle ScholarPubMed
Moller, MB, Ino, Y, Gerdes, AM, Skjodt, K, Louis, DN, Pedersen, NT. Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma. Leukemia, 1999;13(3):453–9.CrossRefGoogle ScholarPubMed
McLendon, R, Rich, J. Glioblastoma stem cells: a neuropathologist’s viewpoint. J Oncol, 2011;2011(article ID 397195).CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×